DBV Technologies S.A. — Director's Dealing 2021

Jan 11, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DBV Technologies S.A. (DBVT)
CIK: 0001613780
Period of Report: 2021-01-01

Reporting Person: Mohideen Pharis (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	15500	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$21.89	2029-07-22	Ordinary Shares (75000)		Direct
Employee Stock Option (right to buy)	$5.09	2030-12-24	Ordinary Shares (95400)		Direct

Footnotes

F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one-half of one Ordinary Share.

F2: Represents shares of the Issuer's ordinary shares underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's ordinary share. 25% of the share underlying the RSU vests on November 24, 2021, and the remaining RSUs vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.

F3: 25% of the shares subject to the Option vested on July 22, 2020, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

F4: This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.223 to EURO 1.00 as of December 31, 2020.

F5: 25% of the shares subject to the Option vest on November 24, 2021, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.